Allspring Global Investments’s Cogent Biosciences COGT Stock Holding History

Allspring Global Investments’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$503K	Buy	14,280 +3,755	+36%	+$139K	﹤0.01%	1387
2025 Q4	$366K	Buy	+10,525	New	+$296K	﹤0.01%	1465
2023 Q3	–	Sell	-434	Closed	-$5.14K	–	2807
2023 Q2	$5.14K	Sell	434 -92,246	-100%	-$1.06M	﹤0.01%	2586
2023 Q1	$1M	Buy	92,680 +91,261	+6,431%	+$1.17M	﹤0.01%	1414
2022 Q4	$16.4K	Sell	1,419 -32	-2%	-$397	﹤0.01%	2628
2022 Q3	$21K	Buy	+1,451	New	+$19.9K	﹤0.01%	2608
2022 Q2	–	Sell	-799	Closed	-$5K	–	2735
2022 Q1	$5K	Sell	799 -93	-10%	-$648	﹤0.01%	2982
2021 Q4	$7K	Buy	+892	New	+$7.75K	﹤0.01%	2926

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Allspring Global Investments's COGT Position: Q1 2026 in Review

Allspring Global Investments increased its Cogent Biosciences (COGT) stake by 36% in Q1 2026, buying an estimated $139K and bringing the position to 14,280 shares worth $503K. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Allspring Global Investments first reported a position in COGT in Q4 2021 and has held it in 8 quarters since. The position peaked at $1M in Q1 2023. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Allspring Global Investments held 14,280 shares of Cogent Biosciences worth $503K as of Q1 2026.
Allspring Global Investments bought 3,755 Cogent Biosciences shares in Q1 2026, an estimated $139K.
Cogent Biosciences made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1387 holding.
Allspring Global Investments first reported a position in Cogent Biosciences in Q4 2021 and has held it in 8 quarters since.
Allspring Global Investments's Cogent Biosciences position peaked at $1M in Q1 2023.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.